<DOC>
	<DOCNO>NCT00527267</DOCNO>
	<brief_summary>Subjects Hemodialysis randomize AMG 073 placebo . The screening period maximum 30 day follow 26-week treatment period . Lab assessment complete throughout study along PRO assessment .</brief_summary>
	<brief_title>Safety Efficacy Study AMG 073 Hemodialysis Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Men Women great equal 18 year age Using effective contraceptive measure Mean iPTH screen great equal 300 pg/mL Mean calcium screen great equal 8.4 mg/dL Stable hemodialysis Unstable medical condition Parathyroidectomy within 3 month Change Vitamin D therapy Receiving antidepressant Experienced MI within 3 month Inability swallow tablet Previously receive AMG 073</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>